Skip to main content
Erschienen in: Archives of Dermatological Research 5/2004

01.10.2004 | Original Paper

1α,25(OH)2D3 regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression

verfasst von: Jette L. Riis, Claus Johansen, Borbala Gesser, Kristine Møller, Christian G. Larsen, Knud Kragballe, Lars Iversen

Erschienen in: Archives of Dermatological Research | Ausgabe 5/2004

Einloggen, um Zugang zu erhalten

Abstract

NF-κB is a dimeric transcription factor which regulates transcription of a number of different genes including IL-8 and p53. In resting cells NF-κB is usually retained in an inactive state in the cytoplasm through binding to a member of the inhibitory κB (IκB) protein family. The purpose of this study was to determine the effect of 1α,25(OH)2D3 on NF-κB activation in both unstimulated and stimulated (IL-1α) cultured normal human keratinocytes. NF-κB DNA binding activity was determined by EMSA using two different oligonucleotides containing the κB sequence from either the IL-8 or the p53 promoter. IκBα and p53 expression was determined by Western blotting and IL-8 expression by ELISA. In unstimulated keratinocytes no NF-κB binding to the IL-8 κB binding sequence was detectable, whereas stimulation with IL-1α (10 ng/ml) led to a significant (P<0.05) induction of NF-κB binding. In contrast NF-κB binding to the p53 κB binding sequence was detectable in unstimulated cells, although it was significantly increased after IL-1α (10 ng/ml) stimulation. Incubation with 1α,25(OH)2D3 (10−8–10−7 M) was shown to significantly (P<0.05) stimulate the expression of IκBα and in parallel experiments with normal human keratinocytes stimulated with IL-1α (10 ng/ml) a significant (P<0.05) time and dose-dependent decrease in NF-κB binding to the IL-8 κB binding sequence and in IL-8 expression were seen. A less-pronounced decrease in NF-κB binding to the p53 κB response element was seen after preincubation with 1α,25(OH)2D3 and IL-1α stimulation, and it did not result in any change in p53 expression. These results demonstrate that 1α,25(OH)2D3 inhibits NF-κB binding to the IL-8 κB binding sequence more potently than binding to the p53 κB binding sequence. We propose that this selectivity may be mediated through an increased expression of IκBα which leads to an inhibition of specific NF-κB subunits resulting in a selective regulation of NF-κB-induced gene transcription.
Literatur
Zurück zum Zitat Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290 Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290
Zurück zum Zitat Baldwin AS (2001a) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107:241–246PubMed Baldwin AS (2001a) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107:241–246PubMed
Zurück zum Zitat Baldwin AS (2001b) The transcription factor NF-κB and human disease. J Clin Invest 107:3–6PubMed Baldwin AS (2001b) The transcription factor NF-κB and human disease. J Clin Invest 107:3–6PubMed
Zurück zum Zitat Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed
Zurück zum Zitat Carlberg C, Polly P (1999) The nuclear receptor superfamily. Retinoids 15:71–74 Carlberg C, Polly P (1999) The nuclear receptor superfamily. Retinoids 15:71–74
Zurück zum Zitat Danning CL, Illie GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43:1244–1256CrossRefPubMed Danning CL, Illie GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43:1244–1256CrossRefPubMed
Zurück zum Zitat De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G (1997) Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94:13504–13509CrossRefPubMed De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G (1997) Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 94:13504–13509CrossRefPubMed
Zurück zum Zitat Foo SY, Nolan GP (1999) NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 15:229–235CrossRefPubMed Foo SY, Nolan GP (1999) NF-κB to the rescue: RELs, apoptosis and cellular transformation. Trends Genet 15:229–235CrossRefPubMed
Zurück zum Zitat Haase I, Hobbs RM, Romero MR, Broad S, Watt FM (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527–536CrossRefPubMed Haase I, Hobbs RM, Romero MR, Broad S, Watt FM (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527–536CrossRefPubMed
Zurück zum Zitat Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ (1997) 1Alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Eur J Biochem 250:63–71CrossRefPubMed Harant H, Andrew PJ, Reddy GS, Foglar E, Lindley IJ (1997) 1Alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression. Eur J Biochem 250:63–71CrossRefPubMed
Zurück zum Zitat Harant H, Wolff B, Lindley IJ (1998) 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett 436:329–334CrossRefPubMed Harant H, Wolff B, Lindley IJ (1998) 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett 436:329–334CrossRefPubMed
Zurück zum Zitat Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM (2001) Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 40:699–703CrossRefPubMed Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM (2001) Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 40:699–703CrossRefPubMed
Zurück zum Zitat Johansen C, Iversen L, Ryborg A, Kragballe K (2000) 1α,25-Dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 114:1174–1179CrossRefPubMed Johansen C, Iversen L, Ryborg A, Kragballe K (2000) 1α,25-Dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 114:1174–1179CrossRefPubMed
Zurück zum Zitat Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L (2003) 1α,25(OH)2D3 stimulates AP-1 DNA binding activity by a PI3-kinase/Ras/MEK/ERK1/2 and JNK1 dependent increase in c-Fos, Fra1 and cJun expression in human keratinocytes. J Invest Dermatol 120:561–570PubMed Johansen C, Kragballe K, Henningsen J, Westergaard M, Kristiansen K, Iversen L (2003) 1α,25(OH)2D3 stimulates AP-1 DNA binding activity by a PI3-kinase/Ras/MEK/ERK1/2 and JNK1 dependent increase in c-Fos, Fra1 and cJun expression in human keratinocytes. J Invest Dermatol 120:561–570PubMed
Zurück zum Zitat Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D (2000) Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 165:3384–3392PubMed Kim J, Sanders SP, Siekierski ES, Casolaro V, Proud D (2000) Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 165:3384–3392PubMed
Zurück zum Zitat Komine M, Watabe Y, Shimaoka S, Sato F, Kake K, Nishina H, Ohtsuki M, Nakagawa H, Tamaki K (1999) The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch Dermatol Res 291:500–506CrossRefPubMed Komine M, Watabe Y, Shimaoka S, Sato F, Kake K, Nishina H, Ohtsuki M, Nakagawa H, Tamaki K (1999) The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes. Arch Dermatol Res 291:500–506CrossRefPubMed
Zurück zum Zitat Kragballe K, Desjarlais L, Marcelo CL (1985) Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 112:263–270PubMed Kragballe K, Desjarlais L, Marcelo CL (1985) Increased DNA synthesis of uninvolved psoriatic epidermis is maintained in vitro. Br J Dermatol 112:263–270PubMed
Zurück zum Zitat Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, Nieboer C, Roed-Petersen J, Strand A, Tikjob G (1991) Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337:193–196CrossRefPubMed Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, Nieboer C, Roed-Petersen J, Strand A, Tikjob G (1991) Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337:193–196CrossRefPubMed
Zurück zum Zitat Kunsch C, Rosen CA (1993) NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13:6137–6146PubMed Kunsch C, Rosen CA (1993) NF-κB subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13:6137–6146PubMed
Zurück zum Zitat Kunsch C, Ruben SM, Rosen CA (1992) Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12:4412–4421PubMed Kunsch C, Ruben SM, Rosen CA (1992) Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol Cell Biol 12:4412–4421PubMed
Zurück zum Zitat Larsen CG, Kristensen M, Paludan K, Deleuran B, Thomsen MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K (1991) 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176:1020–1026PubMed Larsen CG, Kristensen M, Paludan K, Deleuran B, Thomsen MK, Zachariae C, Kragballe K, Matsushima K, Thestrup-Pedersen K (1991) 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem Biophys Res Commun 176:1020–1026PubMed
Zurück zum Zitat Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA (2001) Possible new role for NF-κB in the resolution of inflammation. Nat Med 7:1291–1297CrossRefPubMed Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA (2001) Possible new role for NF-κB in the resolution of inflammation. Nat Med 7:1291–1297CrossRefPubMed
Zurück zum Zitat Lotem J, Sachs L (1998) Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. Proc Natl Acad Sci U S A 95:1330–1337CrossRef Lotem J, Sachs L (1998) Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. Proc Natl Acad Sci U S A 95:1330–1337CrossRef
Zurück zum Zitat McKenzie RC, Sabin E (2003) Aberrant signaling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12:337–345CrossRefPubMed McKenzie RC, Sabin E (2003) Aberrant signaling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12:337–345CrossRefPubMed
Zurück zum Zitat Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N (1999) Benzo[a]pyrene activates human p53 gene through induction of nuclear factor kappa B activity. J Biol Chem 274:35240–35246CrossRefPubMed Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N (1999) Benzo[a]pyrene activates human p53 gene through induction of nuclear factor kappa B activity. J Biol Chem 274:35240–35246CrossRefPubMed
Zurück zum Zitat Phelps CB, Sengchanthalangsy LL, Huxford T, Ghosh G (2000) Mechanism of IκBα binding to NF-κB dimers. J Biol Chem 275:29840–29846CrossRefPubMed Phelps CB, Sengchanthalangsy LL, Huxford T, Ghosh G (2000) Mechanism of IκBα binding to NF-κB dimers. J Biol Chem 275:29840–29846CrossRefPubMed
Zurück zum Zitat Rosette C, Karin M (1995) Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 128:1111–1119CrossRefPubMed Rosette C, Karin M (1995) Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 128:1111–1119CrossRefPubMed
Zurück zum Zitat Rothwarf DM, Karin M (1999) The NF-kappaB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999: RE1PubMed Rothwarf DM, Karin M (1999) The NF-kappaB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999: RE1PubMed
Zurück zum Zitat Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283–286 Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283–286
Zurück zum Zitat Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573–582CrossRefPubMed Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80:573–582CrossRefPubMed
Zurück zum Zitat Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N, Van Waes C (2001) IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7:1812–1820PubMed Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N, Van Waes C (2001) IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 7:1812–1820PubMed
Zurück zum Zitat Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR (1996) Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397–403CrossRefPubMed Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR (1996) Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106:397–403CrossRefPubMed
Zurück zum Zitat Wu H, Lozano G (1994) NF-κB activation of p53. J Biol Chem 269:20067–20074PubMed Wu H, Lozano G (1994) NF-κB activation of p53. J Biol Chem 269:20067–20074PubMed
Zurück zum Zitat Yamamoto K, Nakayama K, Shimizu H, Mitomo K, Fijimoto K (1992) Molecular mechanisms for the regulation of inflammation. Prog Immunol 8:369–376 Yamamoto K, Nakayama K, Shimizu H, Mitomo K, Fijimoto K (1992) Molecular mechanisms for the regulation of inflammation. Prog Immunol 8:369–376
Metadaten
Titel
1α,25(OH)2D3 regulates NF-κB DNA binding activity in cultured normal human keratinocytes through an increase in IκBα expression
verfasst von
Jette L. Riis
Claus Johansen
Borbala Gesser
Kristine Møller
Christian G. Larsen
Knud Kragballe
Lars Iversen
Publikationsdatum
01.10.2004
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 5/2004
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-004-0509-9

Weitere Artikel der Ausgabe 5/2004

Archives of Dermatological Research 5/2004 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.